CTXR

Citius Pharmaceuticals, Inc. - Common Stock (CTXR)

About Citius Pharmaceuticals, Inc. - Common Stock (CTXR)

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.

Details

Daily high

$0.74

Daily low

$0.68

Price at open

$0.71

52 Week High

$26.25

52 Week Low

$0.65

Market cap

7.0M

Dividend yield

0.00%

Volume

206,844

Avg. volume

151,444

P/E ratio

-.12

Citius Pharmaceuticals, Inc. - Common Stock News